Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00013247 · ClinicalTrials.gov registry record · NA
Facilitating Shared Decisionmaking About Prostate Cancer Screening
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 1,152
- Enrollment target
NCT00013247: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT00013247 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 1,152 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00013247, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,152 participants
- Enrollment target
Study Summary
Due to the disputed efficacy of prostate cancer (CaP) screening and treatment, most authorities recommend that providers inform and involve patients in CaP screening decisions.
Interventions
- BEHAVIORAL Prostate Cancer Screening Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,152 participants |
| Est. Completion | 2002-12 |
| Phase | NA |
What the finished NCT00013247 record still lists
NCT00013247 is an interventional study that assigns participants to a tested intervention. Its 1,152 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% lower).
The record links to 0 conditions, and to 1 intervention - of which Prostate Cancer Screening Education is the first listed.
NCT00013247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00013247 about?
NCT00013247 is a clinical study titled "Facilitating Shared Decisionmaking About Prostate Cancer Screening". Due to the disputed efficacy of prostate cancer (CaP) screening and treatment, most authorities recommend that providers inform and involve patients in CaP screening decisions.
What is the current status of trial NCT00013247?
This trial is currently completed. It is a NA study. The enrollment target is 1,152 participants. Estimated completion is 2002-12.
What interventions are being tested in trial NCT00013247?
The interventions under investigation include: Prostate Cancer Screening Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00013247?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00013247's enrollment target sits among peer trials
1,152 92nd of 2000 higher than 1,909 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474301 · 1,152 participants
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
- NCT05564026 · 1,151 participants
Molecular Epidemiology of Pediatric Germ Cell Tumors
- NCT06408181 · 1,150 participants · Phase 3
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
- NCT06528314 · 1,150 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH